The Global market size of Paracetamol is 96,665 metric tonnes & USD 495 Million by volume and by value respectively.
The COVID-19 pandemic had resulted a sudden rise in demand for over-the-counter analgesics like paracetamol, prompting local authorities to impose export restrictions on important pharmaceuticals while keeping adequate stocks in their country.
However, India and China export the majority of paracetamol API. Paracetamol is utilized for painkillers and anti-sickness medicines. It’s also an ingredient in a wide range of cold and flu remedies.
Paracetamol API Developer, and Innovator
The innovator and developer of API of Paracetamol is a Mcneil Consumer Healthcare, the generic molecule is being manufactured by 419 companies out of which, many manufacturers have the USDMF (80 holders), JDMF (14 holders), KDMF (69 holders), CEP/COS (22 holders);
And a few players are Farmson Pharmaceutical Gujarat Pvt Ltd, Granules India Ltd, Sri Krishna Pharmaceuticals Ltd, Hebei Jiheng Group Pharmaceutical Co Ltd, Meghmani LLP, Genfar Ilac , Para Product Pvt Ltd, are some of the major generic manufacturers.
There is an abundance of manufacturing companies in the market, where most of the manufacturers are from China and India, making APAC a far dominated region in the Paracetamol API market.
- For the Paracetamol formulation global market, the total number of formulators is 942, where some of the formulators have USANDA (34 filled), while there is a plethora of European registered formulators, i.e., 2580, who are buying in bulk quantities.
The above-mentioned datapoints have been collected from the Chemxpert database, for more analysis and in-depth insights of the above molecule or other molecules check the below link: https://marketsandsurveys.com/